Clinical Trial Update: A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 study of etavopivat in patients with sickle cell disease and thalassemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Forma Therapeutics, Inc. | Conditions: Sickle Cell Disease, Thalassemia | Phase 2 | Status: COMPLETED